Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 31, 1996 - Issue 8
Submit an article Journal homepage
274
Views
156
CrossRef citations to date
0
Altmetric
Original Article

Omega-3 Fatty Acids and Low Carbohydrate Diet for Maintenance of Remission in Crohn's Disease: A Randomized Controlled Multicenter Trial

H. Lorenz-Meyer Med. Klinik I, Städt. Krankenhaus, Röntgenstr. 2, D-88048, Friedrichshafen, Germany, +49 7541-96-1202
,
P. Bauer Med. Klinik I, Städt. Krankenhaus, Röntgenstr. 2, D-88048, Friedrichshafen, Germany, +49 7541-96-1202
,
C. Nicolay Med. Klinik I, Städt. Krankenhaus, Röntgenstr. 2, D-88048, Friedrichshafen, Germany, +49 7541-96-1202
,
B. Schulz Med. Klinik I, Städt. Krankenhaus, Röntgenstr. 2, D-88048, Friedrichshafen, Germany, +49 7541-96-1202
,
J. Purrmann Med. Klinik I, Städt. Krankenhaus, Röntgenstr. 2, D-88048, Friedrichshafen, Germany, +49 7541-96-1202
,
W. E. Fleig Med. Klinik I, Städt. Krankenhaus, Röntgenstr. 2, D-88048, Friedrichshafen, Germany, +49 7541-96-1202
,
C. Scheurlen Med. Klinik I, Städt. Krankenhaus, Röntgenstr. 2, D-88048, Friedrichshafen, Germany, +49 7541-96-1202
,
I. Koop Med. Klinik I, Städt. Krankenhaus, Röntgenstr. 2, D-88048, Friedrichshafen, Germany, +49 7541-96-1202
,
V. Pudel Med. Klinik I, Städt. Krankenhaus, Röntgenstr. 2, D-88048, Friedrichshafen, Germany, +49 7541-96-1202
&
L. Carr Med. Klinik I, Städt. Krankenhaus, Röntgenstr. 2, D-88048, Friedrichshafen, Germany, +49 7541-96-1202
 show all
Pages 778-785 | Received 20 Sep 1995, Accepted 24 Jan 1996, Published online: 08 Jul 2009

References

  • Stenson E F. Role of eicosapentanoids as mediators of inflammation in inflammatory bowel disease. Scand J Gastroenterol 1990; 25(Suppl 172)13–8
  • Sharon P, Stenson W F. Enhanced sythesis of leucotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 1984; 86: 453–60
  • Lauritsen K, Laursen L S, Bukhave K, Rask‐Madsen J. In vivo profiles of eicosanoids in ulcerative colitis, Crohn's colitis and Clostridium difficile‐colitis. Gastroenterology 1988; 95: 11–7
  • Lee T K, Hoover R I, Williams P D, Sperling R I, Ravalese J, Spur B W, et al. Effect of dietary enrichment with eicosapentanoic and docusahexanoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 1985; 312: 1217–24
  • Endres S, Ghorbani R, Kelley V E, Georgilis K, Lonnemann G, van der Meer J WM, et al. The effect of dietary supplementation with n‐3 polyunsaturated fatty acids on the synthesis of interleukin‐1 and tumor nekrosis factor by mononuclear cells. N Engl J Med 1989; 320: 265–71
  • Wallace J L, Keenan C M, Finn N J. Antiinflammatory effects of a fish oil diet in a rat model of chronic colitis. Gastroenterology 1989; 96: A83
  • Empey L R, Garg M L, Fedorac R N. Eicosapentanoic acid (fish oil)‐enriched diet is protective in rat experimental colitis. Gastroenterology 1989; 96: A83
  • O'Morain C A. Nutritional therapy in ambulatory patients. Dig Dis Sci 1987; 32: 95S–9s
  • Lorenz R, Weber P C, Szimnau P, Heldwein W, Strasser T, Loeschke K, et al. Supplementation with n‐3 fatty acids from fish oil in chronic inflammatory bowel disease—a randomized, placebo‐controlled, double‐blind crossover trial. J Int Med 1989; 225(Suppl 1)225–32
  • Salomon P, Komblut A A, Janowitz H D. Treatment of ulcerative colitis with fish‐oil omega‐3 fatty acids: an open trial. J Clin Gastroenterol 1990; 12: 157–61
  • Greenfield S M, Green A T, Teare J P, Jenkins A P, Punchard N A, Ainley C C, et al. A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis. Aliment Pharmacol Ther 1993; 7: 159–66
  • Katschinsky B, Logan R FA, Edmond M, Langman M JS. Smoking and sugar intake are separate but interactive risk factors in Crohn's disease. Gut 1988; 29: 1202–6
  • Brandes W, Lorenz‐Meyer H. Zuckerfreie Diät: Eine neue Perspektive zur Behandlung des Morbus Crohn? Eine randomisierte Studie. Z Gastroenterol 1981; 19: 1–12
  • Heaton K W, Thornton J R, Emmet P M. Treatment of Crohn's disease with unrefined carbohydrate, fibre‐rich diet. Br Med J 1979; 2: 764–6
  • Alun‐Jones V, Dickinson R J, Woramn E, Wilson A J, Freeman A H, Hunter J O. Crohn's disease: maintainance of remission by diet. Lancet 1985; 2: 177–80
  • Ritchie J, Wadsworth J, Lennard‐Jones J E, Rogers E. Controlled multicenter therapeutic trial of an unrefined carbohydrate, fibrerich diet in Crohn's disease. Br Med J 1987; 295: 517–20
  • Stange E F, Schmid U, Fleig W E, Ditschuneit H. Ausschlußdiät bei Morbus Crohn. Eine kontrollierte, randomisierte Studie. Z Gastreoenterol 1990; 28: 561–4
  • Malchow H, Daiss W. Diagnostik des Morbus Crohn. Dtsch Med Sochenschr 1984; 109: 1770–5
  • Scheurlen M, Clemens M R, Gaede P, Daiss W, Reichert U, Jaschonek K. Eikosapentaen‐ und Docosahexaensäure: Zell‐ und Serumanalysen in Omega‐3 Fettsäuren, G Wechsler, W Swobodnik. Edition Medizin VCH, Weinheim, 1–10
  • BMDP statistical software. University of California Press, Berkeley, [CA] 1988
  • Best W R, Becktel J M, Singleton J W. Development of a Crohn's disease activity index. Gastroenterology 1976; 70: 439–44
  • Lutz W. Morbus Crohn unter kohlehydratarmer Kost. MMW 1987; 50: 921–3
  • Pudel V. Das Check‐List‐Protokoll als einfache Methode zur Erfassung der Ernährungsgewohnheiten Adipöse. Int Z Vitam Ernaehrungsforsch 1974; 44: 246
  • Phillipson B E, Rothrock D W, Connor W E, Harris W S, Illingworth D R. Reduction of plasma lipids, lipoproteins and apoproteins by dietary fish oils in patients with hypertriglycerinemia. N Engl J Med 1985; 312: 1210–6
  • Malchow H, Ewe K, Brandes J W. European cooperative Crohn's disease study (ECCDS): results of drug treatment. Gastroenterology 1984; 86: 249–66
  • Summers R W, Switz D M, Sessions J T, Jr, Becktel J M, Best W R, Kern F, Jr, et al. National Coopertive Crohn's Disease Study: results of drug treatment. Gastroenterology 1979; 77: 847–69
  • Esteve‐Comas M, Raimirez M, Fernandez‐Banarez F, Abad‐Lacruz A, Gil A, Cabre E, et al. Plasma polyunsaturated fatty acid pattern in active inflammatory bowel disease. Gut 1992; 33: 1365–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.